Clinical Trials Browser

Myelodysplastic Syndromes × decitabine and cedazuridine drug combination × Plasma cell × Clear all

NCT02649790 2025-03-19

Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

Phase 1/2 Completed

GastrointestinalMyeloidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Myelodysplastic Syndromes, Colorectal Neoplasms, Leukemia, Myeloid, Acute